Search clinical trials for: Drug Eluting Stent (DES) Coronary Angioplasty

Total 698 results

Instituto Dante Pazzanese de Cardiologia

Recruiting

Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility

Percutaneous Coronary Intervention | Myocardial Dysfunction | STEMI - ST Elevation Myocardial Infarction

Brazil
Poznan University of Medical Sciences

Completed

Complex CAD Treated With PCI With DES Implantation.

Complex Coronary Artery Disease

Poland
Cardionovum GmbH
Mediolanum Cardio Research

Completed

XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization (XLIMIT)

Coronary Artery Disease

Spain, Italy
Brighton and Sussex University Hospitals NHS Trust
Abbott Medical Devices

Completed

Xience or Vision Stent Management of Angina in the Elderly (XIMA)

Coronary Artery Disease

United Kingdom
Andres Iñiguez Romo, MD, PhD

Completed

Randomized Trial of Coronary Angioplasty for de Novo Lesions in sMall vesSElS With Drug Eluting Balloon. (RAMSES)

Coronary Disease

Spain
North Karelia Central Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Recruiting

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Coronary Artery Disease

Finland, France, Germany, United Kingdom
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Biotronik France

Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Coronary Artery Diseases

France
Nanjing First Hospital, Nanjing Medical University

Completed

Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-comers" Coronary Lesions （ULTIMATE Trial） (ULTIMATE)

Coronary Artery Disease

China
Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Papworth Hospital NHS Foundation Trust

Completed

Coronary Microcirculatory and Bioresorbable Vascular Scaffolds (EMPIRE-BVS)

Myocardial Ischemia | Angina, Stable | CHD - Coronary Heart Disease

United Kingdom
Catholic University of the Sacred Heart

Completed

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Saphenous Vein Graft Disease
Aarhus University Hospital Skejby
Odense University Hospital; University of Copenhagen; University of Aarhus

Completed

Comparison of Cypher Select and Taxus Express Coronary Stents (SORT-OUTII)

Coronary Artery Disease | Angina Pectoris
Medtronic Vascular

Completed

Medtronic RevElution Trial (RevElution)

Coronary Artery Disease

Australia, Singapore, Brazil
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Helsinki University Central Hospital

Completed

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) (DRECOREST2)

Vascular Access Complication | Restenosis, Vascular Graft | Dialysis Related Complications
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
A.O. Ospedale Papa Giovanni XXIII
Medtronic; Case Western Reserve University

Completed

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography (OCTAMI)

Acute Myocardial Infarction

Italy
Biotronik AG

Completed

First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions (BIOFLOW-I)

Coronary Artery Disease

Romania
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
Fundación EPIC

Not yet recruiting

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

Coronary Artery Disease
Medical University of Vienna

Completed

Late Acquired Malaposition and Different Polymers

Late Acquired Stent Malaposition

Austria
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Montreal Heart Institute

Completed

Primary Reperfusion Secondary Stenting Trial (PRIMACY)

ST-elevation Myocardial Infarction

France, Canada
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) (RENASCENT III)

Myocardial Ischemia | Coronary Artery Disease

Italy, Colombia
Amaranth Medical Inc.

Unknown

Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (MEND II)

Myocardial Ischemia | Coronary Artery Disease

Colombia
Medtronic Bakken Research Center

Completed

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (eFive)

Coronary Artery Disease
424 General Military Hospital

Completed

Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention (IRICARDIO)

Myocardial Infarction | Coronary Artery Disease

Greece
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT II)

Myocardial Ischemia | Coronary Artery Disease

Colombia, Italy
ReFlow Medical, Inc.

Not yet recruiting

A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)

In-stent Restenosis
Chinese PLA General Hospital

Unknown

Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial

Diffuse Coronary Artery Lesions
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Amaranth Medical Inc.

Unknown

Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT)

Myocardial Ischemia | Coronary Artery Disease

Italy
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Medtronic Vascular

Completed

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries. (ENDEAVORSVS)

Coronary Artery Disease

United States
Yonsei University

Completed

Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Coronary Artery Disease

Korea, Republic of
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Seoul National University Hospital

Unknown

Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database

Coronary Artery Disease | Drug-coated Balloon | Drug-eluting Stents
Medinol Ltd.

Completed

BIONICS Israel Trial

Stenosis

Israel
Helsinki University Central Hospital

Completed

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (DRECOREST1)

Peripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery Restenosis

Finland
Harbin Medical University
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Active, not recruiting

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS) (DCB-ACS)

Coronary Artery Disease | De Novo Stenosis | Clinical Trial | Acute Coronary Syndromes | ACS | DCB | Drug-Coated Balloon

China
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Assiut University

Unknown

Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Diabetes Mellitus, Type 2 With Acute Coronary Syndrom
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Cook Group Incorporated
William Cook Europe; MED Institute, Incorporated; Cook Japan Incorporated

Completed

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (Zilver PTX)

Peripheral Vascular Diseases

United States, Japan, Germany
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan

Search clinical trials for: Drug Eluting Stent (DES) Coronary Angioplasty

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations